ZVSA

4.86

1.62% -0.08

Vorhandelsmarkt: 4.84 -0.02 -0.41%

ZyVersa Therapeutics Inc (ZVSA)

Überblick Nachrichten Preisverlauf Financials Warum fällt ZVSA? Forum Prognose

Schlusskurs vom Vortag:

$4.94

Offen:

$4.9

24-Stunden-Volumen:

25,047

Marktkapitalisierung:

$3.69M

Einnahmen:

Nettoeinkommen (Verlust:

$-98.30M

KGV:

-0.6741

EPS:

-7.2097

Netto-Cashflow:

$-8.72M

1W Leistung:

-7.95%

1M Leistung:

+741.49%

6M Leistung:

+6,329%

1J Leistung:

+1,175%

1-Tages-Spanne:

$4.83

$4.99

52-Wochen-Spanne:

$0.0541

$6.70

ZyVersa Therapeutics Inc Stock (ZVSA) Company Profile

Firmenname

ZyVersa Therapeutics Inc

Sektor

Healthcare (1211)

Branche

Biotechnology (697)

Telefon

754 231 1688

Adresse

2200 N. Commerce Parkway, Suite 208, Weston

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ZVSA's Discussions on Twitter

ZyVersa Therapeutics Inc Aktie (ZVSA) Neueste Nachrichten

ZyVersa Therapeutics reports Q1 EPS ($4.53) vs. ($135.88) last year - TipRanks.com - TipRanks

TipRanks

ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update - GlobeNewswire

GlobeNewswire

ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update

GlobeNewswire Inc.

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention - Yahoo Finance UK

Yahoo Finance UK

ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially ... - br.ADVFN.com

br.ADVFN.com

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) Sees Large Decline in Short Interest - Defense World

Defense World

Finanzdaten der ZyVersa Therapeutics Inc-Aktie (ZVSA)